SMAD4 and gastric cancer: The incidence of cancer in patients with JPS is 11%–86%, with a significantly higher incidence of gastric cancer in those with SMAD4 mutations (10.3%); preventive gastrectomy is recommended in such cases [4, 6, 9, 11].